- Home
- ETON vs FLOC Comparison
ETON vs FLOC Comparison
Compare ETON & FLOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- FLOC
- Stock Information
- Founded
- ETON 2017
- FLOC 1996
- Country
- ETON United States
- FLOC United States
- Employees
- ETON N/A
- FLOC N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- FLOC Metal Fabrications
- Sector
- ETON Health Care
- FLOC Industrials
- Exchange
- ETON Nasdaq
- FLOC Nasdaq
- Market Cap
- ETON 388.3M
- FLOC 417.7M
- IPO Year
- ETON 2018
- FLOC 2025
- Fundamental
- Price
- ETON $17.31
- FLOC $16.31
- Analyst Decision
- ETON Strong Buy
- FLOC Strong Buy
- Analyst Count
- ETON 3
- FLOC 6
- Target Price
- ETON $29.67
- FLOC $30.17
- AVG Volume (30 Days)
- ETON 329.2K
- FLOC 400.4K
- Earning Date
- ETON 08-07-2025
- FLOC 08-05-2025
- Dividend Yield
- ETON N/A
- FLOC 1.96%
- EPS Growth
- ETON N/A
- FLOC N/A
- EPS
- ETON N/A
- FLOC 3.01
- Revenue
- ETON $58,181,000.00
- FLOC $760,923,000.00
- Revenue This Year
- ETON $105.25
- FLOC $47.57
- Revenue Next Year
- ETON $40.84
- FLOC $8.14
- P/E Ratio
- ETON N/A
- FLOC $5.42
- Revenue Growth
- ETON 85.40
- FLOC 155.05
- 52 Week Low
- ETON $4.47
- FLOC $14.89
- 52 Week High
- ETON $21.48
- FLOC $30.50
- Technical
- Relative Strength Index (RSI)
- ETON 61.58
- FLOC 46.36
- Support Level
- ETON $17.02
- FLOC $16.00
- Resistance Level
- ETON $17.77
- FLOC $16.44
- Average True Range (ATR)
- ETON 0.69
- FLOC 0.56
- MACD
- ETON 0.03
- FLOC 0.10
- Stochastic Oscillator
- ETON 78.80
- FLOC 86.32
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About FLOC Flowco Holdings Inc. Class A Common Stock
Flowco Holdings Inc is a provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry. Its technologies include high pressure gas lift (HPGL), conventional gas lift, plunger lift and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions which include rental services and Natural Gas Technologies which include service gas compression parts and equipment sales. Production Solutions: relates to rentals, sales and services related to high pressure gas lift, conventional gas lift and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue.